世界の分子感染症検査市場は、2024年に約162億米ドルと評価され、2025年から2035年の予測期間中、約3.40%の安定した年平均成長率（CAGR）で拡大し、最終的には同期間末までに約234億米ドルに達すると予測されています。現代の診断の礎となる分子感染症検査は、臨床医が比類のない精度とスピードで感染性病原体を識別、監視、管理する方法を変革しました。高度な分子技術を活用したこれらの検査は、病原体から特定の遺伝物質を検出し、早期発見と標的を絞った治療計画を可能にします。市場の成長軌道は、感染症の根強い負担、近年のパンデミック発生に伴う世界的な意識の高まり、そして日常的な医療現場への分子診断の統合増加によって推進されています。さらに、アッセイ設計、自動化ワークフロー、ポイントオブケア分子システムの急速な進歩により、業務効率が向上し、重要な診断のターンアラウンドタイムが短縮されています。
医療提供者がアウトブレイクの抑制と患者の転帰の改善を目指す中、信頼性が高くスループットの高い検査ソリューションへの需要が急増し、市場拡大をさらに促進しています。外来診療所から在宅検査まで、分散型医療環境での分子診断の導入は、業界の関係者に新たな収益源をもたらしました。業界の洞察によると、医療関連感染症の継続的な蔓延と新たな抗菌薬耐性パターンの出現により、検査室はマルチプレックス検出と抗菌薬耐性プロファイリングが可能な分子プラットフォームの導入を余儀なくされています。さらに、人工知能とビッグデータ分析を分子検査ワークフローに統合することで、結果の解釈に革命が起こり、予測疫学とより効率的な公衆衛生介入への道が開かれています。しかし、コストのかかる機器、熟練した検査員の必要性、新興経済国間の診断インフラの格差が、市場浸透の課題として依然として存在しています。
地域別に見ると、北アメリカは2024年に市場の最大シェアを占め、堅牢な医療インフラ、最先端の診断ツールの普及、感染症監視への強力な資金提供の恩恵を受けました。臨床検査室と公衆衛生機関のネットワークが確立されたアメリカは、この分野におけるイノベーションと導入の重要な推進力であり続けています。ヨーロッパは、ゲノム医療への投資増加、迅速な診断導入に対する規制支援、国境を越えた感染症伝播に対する警戒の強化を背景に、これに追随しています。アジア太平洋地域は、患者数の急増、政府主導の医療近代化プログラム、民間部門の診断能力への投資増加を背景に、2035年まで最も急速な成長が見込まれています。中国やインドなどの国々は、都市化、グローバル化、そして変化する疾病疫学の需要に対応するため、分子検査能力を急速に拡大しています。一方、ラテンアメリカと中東・アフリカでは、感染症対策プログラムの強化を目的とした共同イニシアチブやドナー資金によるプロジェクトを通じて、診断エコシステムを徐々に強化しつつあります。
本調査の目的は、近年における様々なセグメントおよび国における市場規模を定義し、今後数年間の価値を予測することです。本レポートは、調査対象国における業界の定性的および定量的側面の両方を網羅するように設計されており、市場の将来の成長を決定づける推進要因や課題といった重要な側面についても詳細な情報を提供しています。さらに、利害関係者が投資できるマイクロ市場における潜在的な機会、そして主要プレーヤーの競争環境と製品提供の詳細な分析も盛り込んでいます。
目次
Table of content
Chapter 1. Global Molecular Infectious Disease Testing Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study (Historical Data - 2023, 2024; Base Year for Estimation - 2024; Forecast period - 2025-2035)
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Molecular Infectious Disease Testing Market Forces Analysis
3.1. Market Forces Shaping The Global Molecular Infectious Disease Testing Market (2024-2035)
3.2. Drivers
3.2.1. Persistent burden of infectious diseases and heightened surveillance post-pandemic
3.2.2. Rising adoption of molecular diagnostics (PCR, multiplex assays) across clinical settings
3.2.3. Increasing demand for rapid, high-throughput and point-of-care testing solutions
3.2.4. Growing emphasis on antimicrobial resistance profiling and precision public health
3.3. Restraints
3.3.1. High capital expenditure for instrumentation and cost per test constraints
3.3.2. Limited skilled laboratory personnel and technical expertise in emerging markets
3.3.3. Regulatory complexities, reimbursement challenges and variability in market access
3.4. Opportunities
3.4.1 Expansion of multiplex assays and syndromic panels for respiratory and bloodstream infections
3.4.2 Decentralization via POC molecular platforms and home-based testing models
3.4.3 Integration of AI/big data for result interpretation and epidemiological forecasting
3.4.4 Market penetration in Asia Pacific, Latin America and Africa through capacity building initiatives
Chapter 4. Global Molecular Infectious Disease Testing Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Molecular Infectious Disease Testing Market Size & Forecasts by Product & Technology 2025-2035
5.1. Market Overview
5.2. Global Molecular Infectious Disease Testing Market Performance - Potential Analysis (2025)
5.3. Instruments
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Reagents
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035
5.5. Mass Spectrometry (Technology)
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.5.2. Market size analysis, by region, 2025-2035
5.6. PCR (Technology)
5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.6.2. Market size analysis, by region, 2025-2035
5.7. In Situ Hybridization (Technology)
5.7.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.7.2. Market size analysis, by region, 2025-2035
Chapter 6. Global Molecular Infectious Disease Testing Market Size & Forecasts by Application 2025-2035
6.1. Market Overview
6.2. Global Molecular Infectious Disease Testing Market Performance - Potential Analysis (2025)
6.3. Respiratory Infections (e.g., SARS, Influenza)
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Bloodstream Infections / Sepsis
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
6.5. Sexually Transmitted Infections
6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.5.2. Market size analysis, by region, 2025-2035
6.6. Gastrointestinal & Other Applications
6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.6.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Molecular Infectious Disease Testing Market Size & Forecasts by Region 2025-2035
7.1. Molecular Infectious Disease Testing Market, Regional Market Snapshot
7.2. Top Leading & Emerging Countries
7.3. North America Molecular Infectious Disease Testing Market
7.3.1. U.S. Molecular Infectious Disease Testing Market
7.3.1.1. Product (Instruments, Reagents) breakdown size & forecasts, 2025-2035
7.3.1.2. Technology (Mass Spec, PCR, ISH) breakdown size & forecasts, 2025-2035
7.3.2. Canada Molecular Infectious Disease Testing Market
7.3.2.1. Product breakdown size & forecasts, 2025-2035
7.3.2.2. Technology breakdown size & forecasts, 2025-2035
7.4. Europe Molecular Infectious Disease Testing Market
7.4.1. UK Molecular Infectious Disease Testing Market
7.4.1.1. Product breakdown size & forecasts, 2025-2035
7.4.1.2. Technology breakdown size & forecasts, 2025-2035
7.4.2. Germany Molecular Infectious Disease Testing Market
7.4.2.1. Product breakdown size & forecasts, 2025-2035
7.4.2.2. Technology breakdown size & forecasts, 2025-2035
7.4.3. France Molecular Infectious Disease Testing Market
7.4.3.1. Product breakdown size & forecasts, 2025-2035
7.4.3.2. Technology breakdown size & forecasts, 2025-2035
7.4.4. Spain Molecular Infectious Disease Testing Market
7.4.4.1. Product breakdown size & forecasts, 2025-2035
7.4.4.2. Technology breakdown size & forecasts, 2025-2035
7.4.5. Italy Molecular Infectious Disease Testing Market
7.4.5.1. Product breakdown size & forecasts, 2025-2035
7.4.5.2. Technology breakdown size & forecasts, 2025-2035
7.4.6. Rest of Europe Molecular Infectious Disease Testing Market
7.4.6.1. Product breakdown size & forecasts, 2025-2035
7.4.6.2. Technology breakdown size & forecasts, 2025-2035
7.5. Asia Pacific Molecular Infectious Disease Testing Market
7.5.1. China Molecular Infectious Disease Testing Market
7.5.1.1. Product breakdown size & forecasts, 2025-2035
7.5.1.2. Technology breakdown size & forecasts, 2025-2035
7.5.2. India Molecular Infectious Disease Testing Market
7.5.2.1. Product breakdown size & forecasts, 2025-2035
7.5.2.2. Technology breakdown size & forecasts, 2025-2035
7.5.3. Japan Molecular Infectious Disease Testing Market
7.5.3.1. Product breakdown size & forecasts, 2025-2035
7.5.3.2. Technology breakdown size & forecasts, 2025-2035
7.5.4. Australia Molecular Infectious Disease Testing Market
7.5.4.1. Product breakdown size & forecasts, 2025-2035
7.5.4.2. Technology breakdown size & forecasts, 2025-2035
7.5.5. South Korea Molecular Infectious Disease Testing Market
7.5.5.1. Product breakdown size & forecasts, 2025-2035
7.5.5.2. Technology breakdown size & forecasts, 2025-2035
7.5.6. Rest of APAC Molecular Infectious Disease Testing Market
7.5.6.1. Product breakdown size & forecasts, 2025-2035
7.5.6.2. Technology breakdown size & forecasts, 2025-2035
7.6. Latin America Molecular Infectious Disease Testing Market
7.6.1. Brazil Molecular Infectious Disease Testing Market
7.6.1.1. Product breakdown size & forecasts, 2025-2035
7.6.1.2. Technology breakdown size & forecasts, 2025-2035
7.6.2. Mexico Molecular Infectious Disease Testing Market
7.6.2.1. Product breakdown size & forecasts, 2025-2035
7.6.2.2. Technology breakdown size & forecasts, 2025-2035
7.7. Middle East and Africa Molecular Infectious Disease Testing Market
7.7.1. UAE Molecular Infectious Disease Testing Market
7.7.1.1. Product breakdown size & forecasts, 2025-2035
7.7.1.2. Technology breakdown size & forecasts, 2025-2035
7.7.2. Saudi Arabia (KSA) Molecular Infectious Disease Testing Market
7.7.2.1. Product breakdown size & forecasts, 2025-2035
7.7.2.2. Technology breakdown size & forecasts, 2025-2035
7.7.3. South Africa Molecular Infectious Disease Testing Market
7.7.3.1. Product breakdown size & forecasts, 2025-2035
7.7.3.2. Technology breakdown size & forecasts, 2025-2035
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Abbott Laboratories
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Financial Performance (Subject to Data Availability)
8.2.5. Product/Services Port
8.2.6. Recent Development
8.2.7. Market Strategies
8.2.8. SWOT Analysis
8.3. Thermo Fisher Scientific Inc.
8.4. Becton, Dickinson and Company (BD)
8.5. F. Hoffmann-La Roche Ltd.
8.6. Danaher Corporation
8.7. Qiagen N.V.
8.8. Hologic, Inc.
8.9. bioMérieux SA
8.10. Illumina, Inc.
8.11. Bio-Rad Laboratories, Inc.
8.12. Siemens Healthineers AG
8.13. GenMark Diagnostics, Inc.
8.14. Agilent Technologies, Inc.
8.15. Luminex Corporation
8.16. Cepheid (a Danaher Company)
List of Tables
Table 1. Global Molecular Infectious Disease Testing Market, Report Scope
Table 2. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Region 2024-2035
Table 3. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Product (Instruments, Reagents) 2024-2035
Table 4. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Instruments, 2024-2035
Table 5. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Reagents, 2024-2035
Table 6. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Technology (Mass Spectrometry, PCR, In Situ Hybridization) 2024-2035
Table 7. Global Molecular Infectious Disease Testing Market Estimates & Forecasts By Application 2024-2035
Table 8. U.S. Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 9. Canada Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 10. UK Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 11. Germany Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 12. France Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 13. Spain Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 14. Italy Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 15. Rest Of Europe Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 16. China Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 17. India Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 18. Japan Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 19. Australia Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 20. South Korea Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 21. Brazil Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 22. Mexico Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 23. UAE Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 24. Saudi Arabia Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 25. South Africa Molecular Infectious Disease Testing Market Estimates & Forecasts, 2024-2035
Table 26. Global Molecular Infectious Disease Testing Market, Company Revenue Comparison 2024
Table 27. Reagent/Consumables Revenue Forecast, 2025-2035
Table 28. Average Selling Price (ASP) Trends, Instruments & Reagents, 2024-2035
Table 29. Installed Base Estimates By Region, 2024
Table 30. Point-of-Care vs Central Lab Adoption Rates, 2024-2035
Table 31. Multiplex Panel Adoption & Revenue Forecast, 2025-2035
Table 32. Regulatory & Reimbursement Landscape Summary by Key Countries
………….
List of Figures
Fig 1. Global Molecular Infectious Disease Testing Market, Research Methodology
Fig 2. Global Molecular Infectious Disease Testing Market, Market Estimation Techniques
Fig 3. Global Market Size Estimates & Forecast Methods
Fig 4. Global Molecular Infectious Disease Testing Market, Key Trends 2025
Fig 5. Global Molecular Infectious Disease Testing Market, Growth Prospects 2024-2035
Fig 6. Global Molecular Infectious Disease Testing Market, Porter’s Five Forces Model
Fig 7. Global Molecular Infectious Disease Testing Market, PESTEL Analysis
Fig 8. Global Molecular Infectious Disease Testing Market, Value Chain Analysis
Fig 9. Molecular Infectious Disease Testing Market By Product, 2025 & 2035
Fig 10. Molecular Infectious Disease Testing Market By Technology, 2025 & 2035
Fig 11. Molecular Infectious Disease Testing Market By Application, 2025 & 2035
Fig 12. Molecular Infectious Disease Testing Market By End-use, 2025 & 2035
Fig 13. Molecular Infectious Disease Testing Market By Segment, 2025 & 2035
Fig 14. North America Molecular Infectious Disease Testing Market, 2025 & 2035
Fig 15. Europe Molecular Infectious Disease Testing Market, 2025 & 2035
Fig 16. Asia Pacific Molecular Infectious Disease Testing Market, 2025 & 2035
Fig 17. Latin America Molecular Infectious Disease Testing Market, 2025 & 2035
Fig 18. Middle East & Africa Molecular Infectious Disease Testing Market, 2025 & 2035
Fig 19. Global Molecular Infectious Disease Testing Market, Company Market Share Analysis (2025)
Fig 20. Molecular Infectious Disease Testing Market — Average Selling Price Trend, 2024-2035
Fig 21. Installed Base Growth by Region, 2024-2035
Fig 22. Revenue Contribution — Instruments vs Reagents vs POC, 2025 & 2035
Fig 23. Technology Adoption Curve — PCR vs Mass Spec vs ISH
Fig 24. Forecast Sensitivity Analysis, CAGR Scenarios (2025-2035)
Fig 25. Key Regulatory Approval Timelines by Region
